Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Pancreatic Surgery (NEUPRODEX)
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2019
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Delirium
- Focus Therapeutic Use
- Acronyms Neuprodex
- 31 Aug 2018 Biomarkers information updated
- 20 Aug 2018 Status changed from recruiting to completed.
- 16 Mar 2018 Planned number of patients changed from 87 to 77.